Systematic Alpha Investments LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA – Get Rating) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,238 shares of the company’s stock, valued at approximately $812,000.
Several other large investors also recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its holdings in HCA Healthcare by 1.9% during the fourth quarter. BlackRock Inc. now owns 16,377,032 shares of the company’s stock worth $4,207,588,000 after buying an additional 313,091 shares during the period. Sanders Capital LLC raised its position in shares of HCA Healthcare by 16.9% during the 4th quarter. Sanders Capital LLC now owns 9,448,037 shares of the company’s stock worth $2,650,774,000 after purchasing an additional 1,365,582 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 3,793,750 shares of the company’s stock valued at $971,719,000 after purchasing an additional 10,724 shares during the period. Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter valued at about $596,396,000. Finally, Boston Partners lifted its holdings in shares of HCA Healthcare by 32.7% during the first quarter. Boston Partners now owns 1,123,394 shares of the company’s stock valued at $281,553,000 after purchasing an additional 276,890 shares during the last quarter. 67.87% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on HCA shares. BMO Capital Markets cut HCA Healthcare from a “market perform” rating to an “underperform” rating and decreased their price target for the company from $233.00 to $160.00 in a report on Wednesday, July 6th. Jefferies Financial Group reduced their price target on shares of HCA Healthcare from $310.00 to $275.00 in a report on Monday, April 25th. Mizuho lifted their target price on HCA Healthcare from $210.00 to $230.00 and gave the company a “buy” rating in a report on Tuesday, August 2nd. Sanford C. Bernstein raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and decreased their target price for the stock from $273.00 to $271.00 in a report on Thursday, May 26th. Finally, Royal Bank of Canada decreased their target price on HCA Healthcare from $267.00 to $256.00 and set an “outperform” rating for the company in a research report on Tuesday, June 21st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $236.81.
HCA Healthcare Stock Down 1.2 %
HCA Healthcare (NYSE:HCA – Get Rating) last announced its quarterly earnings data on Friday, July 22nd. The company reported $4.21 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.54. The company had revenue of $14.82 billion during the quarter, compared to the consensus estimate of $14.73 billion. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.37 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 17.05 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be given a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a yield of 1.06%. The ex-dividend date is Thursday, September 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.77%.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, major shareholder Patricia F. Elcan purchased 325 shares of the stock in a transaction dated Monday, July 25th. The shares were bought at an average price of $198.66 per share, with a total value of $64,564.50. Following the completion of the transaction, the insider now directly owns 89,337 shares in the company, valued at approximately $17,747,688.42. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.50% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- Agilent Technologies Proves Its Worth VS Illumina
- Lowe’s Stands Out Amid Q2 Retail Reports
- Target’s Results Cap Upside Potential For Retail Stocks
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.